M C Jacob|M Favre|J C Bensa - JoVE Visualize

Showing results (11-20 of 199) with videos related to

Pageof 20

Sort By:

Blood|May 16, 1998

Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.

European Journal of Immunology|December 1, 1995

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.

Experimental Hematology|March 25, 1999

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.

Blood|March 1, 1990

T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant cloneM C Jacob, M P Piccinni, T Bonnefoix, et al.

Presse Medicale (Paris, France : 1983)|November 17, 1983

[Role of immunoglobulins in the activation of complement]M G Colomb, J C Bensa

Leukemia & Lymphoma|March 14, 1998

Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomasL Chaperot, M C Jacob, F Le Vacon, et al.

Leukemia|July 31, 2004

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory responseN Bendriss-Vermare, L Chaperot, M Peoc'h, et al.

The Biochemical Journal|January 15, 1986

Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cellsA Reboul, J C Bensa, M G Colomb

The Biochemical Journal|November 15, 1983

Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytesJ C Bensa, A Reboul, M G Colomb

Leukemia|September 20, 2000

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphomaL Chaperot, M Chokri, M C Jacob, et al.

Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:

Pageof 20

Blood|May 16, 1998

Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.

European Journal of Immunology|December 1, 1995

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.

Experimental Hematology|March 25, 1999

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.

Blood|March 1, 1990

T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant cloneM C Jacob, M P Piccinni, T Bonnefoix, et al.

Presse Medicale (Paris, France : 1983)|November 17, 1983

[Role of immunoglobulins in the activation of complement]M G Colomb, J C Bensa

Leukemia & Lymphoma|March 14, 1998

Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomasL Chaperot, M C Jacob, F Le Vacon, et al.

Leukemia|July 31, 2004

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory responseN Bendriss-Vermare, L Chaperot, M Peoc'h, et al.

The Biochemical Journal|January 15, 1986

Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cellsA Reboul, J C Bensa, M G Colomb

The Biochemical Journal|November 15, 1983

Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytesJ C Bensa, A Reboul, M G Colomb

Leukemia|September 20, 2000

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphomaL Chaperot, M Chokri, M C Jacob, et al.

Pageof 20